CleanSpace Holdings Limited (ASX: CSX) - Share Price
- Current share price for CSX : $0.405
CleanSpace Holdings Limited (CSX), an ASX-listed company, is engaged in design, manufacture and sale of respirators and related products and services. The Company's respirator solutions use patented technology and miniaturisation design (collectively called AirSensit) that improve personal respiratory protection against dust, biological and gas airborne hazards.
CSX General Information +
| ASX Code | CSX |
| Website | http://www.cleanspacetechnology.com |
| Industry/Sector | Health Care Equipment |
| Market Cap ($M) | 32 |
| CSX Share Price | $0.405 |
| Day High | $0.000 |
| Day Low | $0.000 |
| Last Close | $0.405 |
| CSX Share Price Movement | - ( No change ) |
Prices as at 16:40, 30 Jul 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
CleanSpace Holdings Limited (CSX) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from CleanSpace Holdings Limited (CSX) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
CleanSpace Holdings Limited (CSX) price-sensitive announcements
CSX - AGILE achieves Australia and New Zealand certification
CleanSpace Holdings Limited, a Sydney-based company specializing in respiratory protection
CleanSpace Holdings Limited (CSX)
23 Jun 2026 | 8:40 AM
23 Jun 2026 | 8:40 AM
CSX - New Product Launch - CleanSpace AGILE
On June 11, 2026, CleanSpace Holdings Limited announced the launch of CleanSpace AGILE, a
CleanSpace Holdings Limited (CSX)
11 Jun 2026 | 9:46 AM
11 Jun 2026 | 9:46 AM
CSX - FY26 Trading Update
CleanSpace Holdings Limited has issued a trading update for FY26, projecting a small growt
CleanSpace Holdings Limited (CSX)
26 May 2026 | 2:33 PM
26 May 2026 | 2:33 PM
CSX - H1 FY26 Results
CleanSpace Holdings Limited reported its H1 FY26 results, showing a 10% revenue growth to
CleanSpace Holdings Limited (CSX)
26 Feb 2026 | 8:51 AM
26 Feb 2026 | 8:51 AM
CleanSpace Holdings Limited (CSX) Recent ASX Announcements
CSX Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2025A | $0.22 | $0.30 | -106.90% | 154.20 | 0.00 | 0.00% | 0.0% |
| 2024A | -$3.13 | -$4.10 | -61.70% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2023A | -$8.13 | -$10.60 | -27.90% | 0.00 | 0.00 | 0.00% | 0.0% |
CSX Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | ||
| Cochlear Limited (COH) | $8,011M | 0.0171 | -0.1894 | 0.0615 | 20.4702 | 25.2536 | 23.7896 | 3.51% | 2.83% | 2.94% |
| CleanSpace Holdings Limited (CSX) | $32M | -1.0691 | 0.0000 | 0.0000 | 144.6429 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Fisher & Paykel Healthcare Corporation Limited (FPH) | $20,362M | 0.1388 | 0.1414 | 0.1883 | 52.4270 | 45.9327 | 38.6554 | 1.25% | 1.34% | 1.52% |
| ResMed Inc. (RMD) | $17,814M | 0.3087 | 9.7744 | 0.0595 | 206.2586 | 19.1434 | 18.0684 | 1.12% | 1.17% | 1.23% |
CSX Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.70 | 144.60 | 1.65 | 0.00 |
| Market | 0.32 | 12.80 | 1.12 | 0.58 |
| Sector | 0.71 | 19.60 | 1.58 | 1.77 |
CSX Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Dan Kao | Director-Operations & Founder, Executive Director | 1 Apr 2011 |
| Mr Graham McLean | Executive Director, Executive Chairman | 1 Feb 2022 |
| Ms Lisa Ray Hennessy | Non-Executive Director | 9 Dec 2021 |
| Mr Paul Cassano | Non-Executive Director | 1 Sep 2023 |
CleanSpace Holdings Limited (CSX) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 9 Mar 2026 | MCLEAN, Graham | Buy | Indirect Shares | 59,984 | $0.519 | $31,148.610 |
| 9 Mar 2026 | MCLEAN, Graham | Issued | Indirect Shares | 37,500 | $0.545 | $20,437.500 |
| 9 Mar 2026 | MCLEAN, Graham | Exercise | Related Securities | 37,500 | $0.545 | $20,437.500 |
See all changes in directors' interest & trades for CleanSpace Holdings Limited (CSX) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
CSX Management
| Name | Position |
|---|---|
| Gabrielle O'Carroll | Chief Executive Officer |
| Bree Greef | Chief Financial Officer |
| Elissa Hansen | Company Secretary |
CSX Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in CleanSpace Holdings Limited (CSX). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 9,314,480 (12.09%) | Jencay Capital Pty Limited |
| 9,257,535 (12.02%) | One Fund Services Ltd |
| 4,163,550 (5.37%) | Acorn Capital Limited |
CSX Calendar of Events
| Date | Event |
|---|---|
| 25 February 2027 | Report (Interim) |
| 25 August 2026 | Report (Annual) |
| 25 August 2026 | Report (Prelim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
